The remaining genotypes—HR-HPV 45, 52, and P1 (including HR-HPV 33, 58)—even though they did not reach statistical significance due to the low number of the available samples, reductions of 91%, 77%, and 59% were achieved after PHMB treatment, respectively.
← all excerpts
Polyhexamethylene Biguanide Reduces High-Risk Human Papilloma Virus Viral Load in Cervical Cell Samples Derived from ThinPrep Pap Test.
1
—
—